Akorn Enterprises, Inc., and Hi-Tech Pharmacal, Inc., will sell the rights and assets to three generic prescription eye medication and two general topical anesthetics to Watson Laboratories, Inc., to settle FTC...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: